TN2010000611A1 - Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer - Google Patents

Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer

Info

Publication number
TN2010000611A1
TN2010000611A1 TNP2010000611A TN2010000611A TN2010000611A1 TN 2010000611 A1 TN2010000611 A1 TN 2010000611A1 TN P2010000611 A TNP2010000611 A TN P2010000611A TN 2010000611 A TN2010000611 A TN 2010000611A TN 2010000611 A1 TN2010000611 A1 TN 2010000611A1
Authority
TN
Tunisia
Prior art keywords
cancer
treatment
combination
aminoheteroaryl compound
met antagonist
Prior art date
Application number
TNP2010000611A
Other languages
French (fr)
Inventor
Liliane Goetsch
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/058709 external-priority patent/WO2010003992A1/en
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TN2010000611A1 publication Critical patent/TN2010000611A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention also relates to a composition comprising an antibody antagonist to c-Met and an aminoheteroaryl compound, particularly as a medicament. The present invention also comprises a pharmaceutical composition comprising said anti c-Met antibody and said aminoheteroaryl compound as combination products for simultaneous, separate or sequential use. The invention relates to the use of the composition of the invention for the treatment of cancer in a mammal.
TNP2010000611A 2009-07-08 2010-12-27 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer TN2010000611A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/058709 WO2010003992A1 (en) 2008-07-08 2009-07-08 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer

Publications (1)

Publication Number Publication Date
TN2010000611A1 true TN2010000611A1 (en) 2012-05-24

Family

ID=55024683

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000611A TN2010000611A1 (en) 2009-07-08 2010-12-27 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer

Country Status (1)

Country Link
TN (1) TN2010000611A1 (en)

Similar Documents

Publication Publication Date Title
MX2011000255A (en) Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer.
IL255752B (en) Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer
WO2011099832A3 (en) Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
IL223783B (en) Substituted 1-indole compound for use in the treatment of a disease or condition, a pharmaceutical composition comprising the compound and use of the compound for the preparation of a medicament
GB201118656D0 (en) New compounds
MY166014A (en) Combination therapy methods for treating proliferative diseases
AU2010233994A8 (en) Bispecific anti-ErbB-3/anti-c-Met antibodies
MY160456A (en) Benzodiazepine bromodomain inhibitor
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
WO2014062720A3 (en) Methods of treating cancer
PL2532364T3 (en) Pharmaceutical composition comprising anti caprin-1 antibodies for treating and/or preventing cancer
MY158560A (en) Composition comprising antiboby that binds to domain ii of her2 and acidic variants thereof
MX349004B (en) New compounds.
MX366899B (en) New compounds.
IN2012DN02018A (en)
MX347893B (en) Human antibody drug conjugates against tissue factor.
WO2011127333A3 (en) Compounds for treating disease, for administering, and for pharmaceutical compositions
MX350200B (en) Human antibodies and antibody-drug conjugates against cd74.
JOP20110402B1 (en) Anti-cd38 antibodies
MX2019000225A (en) Compositions and methods for treatment of autoimmune and other disease.
EA033311B1 (en) Benzoxaborole derivatives as antibacterial agents
PH12014502406B1 (en) Anti-il-23p19 antibodies
WO2012032209A3 (en) Pharmaceutical composition for the treatment of dry eye
MX347734B (en) S100a4 antibodies and therapeutic uses thereof.
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer